...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: find it interesting that RVXCF.....

tada, correct it if I'm wrong but this is the way I see it.

Resverlogix's clinical ambitions thus far focused on its therapeutic potential (apabetalone) in the treatment of Vascular Disease, Covid-19 & Post Covid-19 conditions.

Zenith is focused on the development of the BETi combination therapies for multiple oncology indications, with its lead BET inhibitor, ZEN-3694 in collaboration with BP in several oncology clinical studies.

 

Koo

 

 

Share
New Message
Please login to post a reply